{
    "2021-03-15": [
        [
            {
                "time": "",
                "original_text": "医药行业：创新药周报",
                "features": {
                    "keywords": [
                        "医药行业",
                        "创新药",
                        "周报"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：拟发行H股并在香港联交所上市的申请已获得中国证监会受理",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "H股",
                        "香港联交所",
                        "证监会",
                        "受理"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国际权威肿瘤学家毛力出任丽珠生物CEO；朱凌宇博士出任首席商务官",
                "features": {
                    "keywords": [
                        "国际权威",
                        "肿瘤学家",
                        "毛力",
                        "丽珠生物",
                        "CEO",
                        "朱凌宇",
                        "首席商务官"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业一周观察：板块战略配置价值显现 关注成长性与估值的匹配",
                "features": {
                    "keywords": [
                        "医药行业",
                        "一周观察",
                        "板块",
                        "战略配置",
                        "成长性",
                        "估值"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}